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To the Editor: Although he stresses the usefulness of the serum-ascites albumin gradient, Runyon claims
that measurement of fibronectin or cholesterol in ascitic fluid is not useful for the differential diagnosis of
ascites. We have a different view. A test for fibronectin1 or cholesterol2 in ascitic fluid can accurately
discriminate between malignant and nonmalignant ascites and is superior to protein measurement for
this purpose. The serum-ascites albumin gradient may be inferior to ascitic-fluid cholesterol
measurement in the differential diagnosis of ascites3,4,5. For these reasons, we advocate the
measurement of ascitic-fluid cholesterol.
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